Información del producto
Tetraglyme-d6 is a medicinal compound that has been developed as an analog of a protein kinase inhibitor. This compound has shown potent anticancer activity in human cancer cells and has been found to induce apoptosis, or programmed cell death, in tumor cells. Tetraglyme-d6 inhibits the activity of kinases, which are enzymes that play a critical role in the regulation of cellular processes such as growth and division. This inhibition leads to the suppression of cancer cell growth and proliferation. The compound has been tested extensively in Chinese hamster ovary cells and its efficacy as an anticancer agent has been demonstrated in vivo. Furthermore, it has also been detected in urine samples from patients with cancer who have received treatment with this inhibitor. Tetraglyme-d6 is a promising candidate for further development as a potent anticancer drug.
Propiedades químicas
Consulta técnica sobre: 3D-RYB62815 Tetraglyme-d6
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
